The efficacy of melatonin for sleep problems in children with autism, fragile X syndrome, or autism and fragile X syndrome.
about
Clinical uses of melatonin in pediatricsA review of complementary and alternative treatments for autism spectrum disordersThe 22q13.3 Deletion Syndrome (Phelan-McDermid Syndrome)The neurology of autism spectrum disordersFragile X spectrum disordersEmerging pharmacologic treatment options for fragile X syndromeFragile X syndrome and targeted treatment trials.Fragile X syndromeUnstable mutations in the FMR1 gene and the phenotypesMelatonin Treatment in Children with Developmental DisabilitiesMedical treatment overview: traditional and novel psycho-pharmacological and complementary and alternative medicationsFragile X syndrome: A review of clinical managementAutism as a disorder of biological and behavioral rhythms: toward new therapeutic perspectivesAdvances in the research of melatonin in autism spectrum disorders: literature review and new perspectivesTreatments for fragile X syndrome: a closer look at the data.Identification of pathway-biased and deleterious melatonin receptor mutants in autism spectrum disorders and in the general population.Sleep in Neurodevelopmental Disorders.Updated report on tools to measure outcomes of clinical trials in fragile X syndrome.Prevalence, nature, and correlates of sleep problems among children with fragile X syndrome based on a large scale parent survey.Melatonin as a Novel Interventional Candidate for Fragile X Syndrome with Autism Spectrum Disorder in HumansA combination of ascorbic acid and α-tocopherol to test the effectiveness and safety in the fragile X syndrome: study protocol for a phase II, randomized, placebo-controlled trialModulation of the GABAergic pathway for the treatment of fragile X syndrome.Autism spectrum features in Smith-Magenis syndrome.Molecular Advances Leading to Treatment Implications for Fragile X Premutation CarriersSocial peers rescue autism-relevant sociability deficits in adolescent mice.Daytime sleep patterns in preschool children with autism, developmental delay, and typical development.Prevalence and Predictors of Complementary and Alternative Medicine Use in a Large Insured Sample of Children with Autism Spectrum DisordersUse of actigraphy for assessment in pediatric sleep research.Six-month sleep-wake organization and stability in preschool-age children with autism, developmental delay, and typical developmentThe Healthy Heart-Mind trial: melatonin for prevention of delirium following cardiac surgery: study protocol for a randomized controlled trial.Dissolution of Intact, Divided and Crushed Circadin Tablets: Prolonged vs. Immediate Release of MelatoninRelation of melatonin to sleep architecture in children with autism.Offering fragile X syndrome carrier screening: a prospective mixed-methods observational study comparing carrier screening of pregnant and non-pregnant women in the general populationTreatment of Autism Spectrum Disorder in Children and Adolescents.Neurocognitive endophenotypes in CGG KI and Fmr1 KO mouse models of Fragile X-Associated disorders: an analysis of the state of the fieldComplementary and alternative medicine in autism: an evidence-based approach to negotiating safe and efficacious interventions with families.What's in the pipeline? Drugs in development for autism spectrum disorder.Serotonin dysregulation in Fragile X Syndrome: implications for treatment.Public Health Literature Review of Fragile X Syndrome.New Developments in Insomnia Medications of Relevance to Mental Health Disorders.
P2860
Q21296744-59E83229-E50A-4BC5-BD2C-84A02231CFA9Q24603000-29919BFC-FF0C-4869-BDBF-9351266AD465Q24612792-293FE85C-F708-432C-BB62-DEFCD9727596Q24612945-6266B3D0-44DF-4A09-A628-FDEEAFA676DFQ26824376-DE557F9D-AC44-4C2E-BC25-46AF06B077D2Q26829152-111F6132-A59A-4CD3-9425-8BD660F7255BQ26865162-3A56B99B-AC6F-49AB-AC5C-F63BA72A70CFQ26995168-0B332A6E-94B5-4A73-8F67-8F6FC0C8F163Q26996649-3B469ABA-3096-4CFA-B53F-91098B6C396CQ27012836-B77E9EE7-DA96-4E55-8580-B0664A78D396Q27014201-4828937D-F1F7-4C03-95E0-ACF7F6E2C2B4Q28076950-939FA688-59BD-405D-85F0-D8E808790A41Q28080719-DD5B89CE-0EFA-4888-BFF9-49D16F0F345FQ28661706-3F65151C-EC88-4D6A-9AC1-5CA0C35A974CQ33518808-6B3148E0-86A9-4875-AF83-211377ACD9A8Q33640009-36022D8D-0D82-4459-96EE-C45E309ADC4BQ33655855-465A7FC7-CE4D-45A2-9C7B-7258A11BBF8AQ33785978-A4A95FD1-F077-4338-A941-FE3CFAFB2B38Q33830944-C9A87F5F-019F-487C-9156-28477EED23C4Q33839140-986D8CBE-80CC-4226-A5B5-593FCFAC82B7Q34207747-FF2C54FC-6EF6-4DB0-B435-BEA7FFDF1A17Q34230612-5BD2CFF5-8852-4FF3-953D-F2B86828FBF6Q34257621-CB7AE8FB-2895-40F8-BBB0-692E3B817675Q34575595-C73D53C4-35F3-4C98-8C02-AE22B3C86413Q34730502-6CBDAC55-6649-4642-9553-850A39851ABAQ35767667-AF44D868-0D7D-496A-86B0-43EB0426A744Q36036144-275F483A-BCFF-4BDA-8CD1-382549DFCC28Q36243136-7A68939D-D76E-4B9F-B8CD-7A502587781AQ36401129-56A94573-9753-4178-9B5E-669B35E16A23Q36513971-B6AF6932-5E83-4C4B-8400-1406F62BAD08Q36735320-B800EA0C-DF28-4D6C-B443-EAFEC7B26CB8Q37101390-7B9E8C1D-C4A7-439A-96B8-3BDE8CA6AD58Q37172649-5E9FDDA7-EE7E-4475-90C7-88A51C09D3D5Q37299857-FC0E4B27-163D-4BE1-B7C3-799619AC4B22Q37623407-B0A08C5C-8CE3-4A55-8562-E4DAD709402AQ37774100-C3406E6A-5E7F-4A56-B9B8-2214BF0D6B57Q38193069-5DF0B675-0907-445D-A771-12E8BB09C0C0Q38326506-EBCC46FF-CB32-4537-8A07-0952686D4270Q38641503-03EC5B83-4E6D-4898-8E51-57AADEBDF7F4Q38645553-CA5C5ADB-4E0F-495B-9103-E1DB401279AE
P2860
The efficacy of melatonin for sleep problems in children with autism, fragile X syndrome, or autism and fragile X syndrome.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The efficacy of melatonin for ...... autism and fragile X syndrome.
@en
The efficacy of melatonin for ...... autism and fragile X syndrome.
@nl
type
label
The efficacy of melatonin for ...... autism and fragile X syndrome.
@en
The efficacy of melatonin for ...... autism and fragile X syndrome.
@nl
prefLabel
The efficacy of melatonin for ...... autism and fragile X syndrome.
@en
The efficacy of melatonin for ...... autism and fragile X syndrome.
@nl
P2093
P2860
P1476
The efficacy of melatonin for ...... autism and fragile X syndrome
@en
P2093
Beth L Goodlin-Jones
Juthamas Wirojanan
Rafael Diaz
Randi J Hagerman
Sebastien Jacquemont
Susan Bacalman
Thomas F Anders
P2860
P304
P407
P577
2009-04-01T00:00:00Z